As Tanzania grapples with Marburg Virus outbreak: What you need to know


Date Published

Marburg virus disease is a severe, often fatal illness. It begins with flu-like symptoms but can escalate to severe vomiting, bleeding, and neurological complications. The disease is typically transmitted from bats or primates to humans and can then spread person-to-person, fueling outbreaks. Marburg virus is a type of hemorrhagic fever, caused by a virus in the same family as Ebola, known for damaging blood vessels and causing internal and external bleeding.

Tanzania is currently battling a new outbreak MVD and has reported one confirmed case and 25 suspected cases, following laboratory tests that identified the infection, raising alarm across the region. The outbreak underscores the critical need for vigilance, early detection, and robust containment measures to prevent further escalation.

How Common is Marburg Virus Disease?
While rare, Marburg virus disease outbreaks can range from a handful of cases to hundreds, making its containment critical.

Other recent and notable outbreaks
Equatorial Guinea (2023): 16 confirmed cases, 12 deaths.
Tanzania (2023): 8 confirmed cases, 5 deaths.

Historical outbreaks
Uganda (2012): 15 cases, 4 deaths.
Angola (2004–2005): 252 cases, 227 deaths.
DRC (1998–2000): 154 cases, 128 deaths (primarily in mine workers).
Germany & Yugoslavia (1967): 31 cases, 7 deaths (linked to handling African green monkeys).

What are the symptoms?
MVD symptoms typically appear in two phases:
Initial Phase (5–7 days):
Fever, chills, headache, muscle pain, sore throat, rash, and cough.

Advanced phase:
Severe abdominal pain, vomiting, diarrhea, dizziness, weight loss, and bleeding from the nose, mouth, or eyes.

Seek immediate medical attention if these symptoms arise.

What causes MVD?
The disease is caused by two viruses: Marburg virus (MARV), Ravn virus (RAVV)
Both belong to the Filoviridae family, the same as the Ebola virus.

How does the virus spread?
MVD spreads through contact with:
Infected body fluids like blood, saliva, urine, or semen.
Contaminated surfaces.
Bats or primates carrying the virus.

Risk factors include working with animals, visiting caves where fruit bats live, or caring for infected individuals.

Diagnosis and treatment
A blood test confirms the disease. Early diagnosis is critical as symptoms often mimic malaria or typhoid. Always inform healthcare providers of recent travel or exposure to outbreak areas.

Is there a cure?
Currently, no specific cure exists. Treatment focuses on supportive care, including:
Oxygen therapy.
Intravenous fluids.
Managing complications like dehydration or pain.

How can Marburg virus be prevented?
Use protective equipment (masks, gloves, goggles) when caring for patients.
Avoid contact with infected body fluids or contaminated items.
Practice safe burials: Ensure safe handling of the deceased to prevent exposure to bodily fluids.
No handshaking
Refrain from handling bush meat, bats, or primates.
Monitor for symptoms for 21 days after potential exposure and seek care immediately if symptoms develop.

If you suspect infection:
If you think you may have been exposed or experience symptoms:
Seek medical care immediately: Early treatment can save lives.
Isolate yourself: Avoid contact with others to prevent spread.
Notify local health authorities: Visit the nearest healthcare facility for evaluation.

Outlook and prognosis
What should you expect with MVD?
Patients require isolation and close monitoring. Survivors may face long-term complications, including memory issues, muscle pain, or hair loss. The virus can persist in bodily fluids like semen, so continued precautions are necessary.

Is survival possible?
With an average fatality rate of 80%, early medical care is crucial. Mortality rates vary significantly between outbreaks (24%–90%).

When to see a Doctor
If you’ve travelled to an outbreak area or had possible exposure, monitor for symptoms for 21 days. Report any symptoms immediately to healthcare providers and disclose potential exposure to facilitate early diagnosis and care.

Read more:

Tanzania confirms Marburg Virus outbreak: https://rcc.eac.int/node/150 

Marburg Key Facts:   Transmission, Symptoms, Diagnosis, Treatment 

 

 

 



Article Type

Sector

History of Marburg outbreaks


Date Published

Most Marburg virus disease (Marburg) outbreaks have occurred in Sub-Saharan Africa. However, the virus has spread to across the world through infected travelers or accidental laboratory infections. The disease is named for the German city where scientists became ill with the disease's first known cases in 1967, while handling monkeys imported from Africa. Read here as the US Centers for Disease Control tracks the history of the disease.  

 



Article Type

Sector

Critical lessons from Rwanda’s response to the Marburg Virus outbreak


Date Published

The Marburg virus outbreak in Rwanda in late 2024 underscores the importance of community-driven and adaptive public health strategies. A detailed brief highlights key lessons, including the vital role of leveraging decentralized systems for effective community engagement, addressing local perceptions through qualitative assessments, and safeguarding healthcare workers with enhanced protective measures. With vaccination efforts targeting high-risk groups, Rwanda’s approach offers valuable insights into managing outbreaks while respecting cultural practices and mitigating misinformation.

Community Engagement: Leveraging Rwanda's decentralized administrative system, which includes elected village leaders and Community Health Workers, is vital for disseminating public health messages. Engaging trusted local channels such as religious leaders, women's and youth organizations, and trade cooperatives can enhance the adoption of preventive measures. Utilizing media platforms like radio and social media, along with community meetings, further strengthens outreach efforts. Involving community members in adapting Safe and Dignified Burial protocols ensures cultural practices are respected.

Rapid Qualitative Assessments: Understanding community perceptions, behaviors, and concerns is crucial. Conducting assessments to explore fears related to quarantine, healthcare facilities, and vaccine safety, as well as addressing rumors or misinformation, allows for culturally sensitive adjustments in risk communication and intervention strategies.

Healthcare Worker Protection: With over 70% of reported cases among health workers, enhancing protection and rigorous infection prevention control practices are imperative. Importing personal protective equipment (PPE) to support healthcare workers and volunteers is essential to mitigate nosocomial transmission risks.

Vaccination Efforts: Prioritizing healthcare workers in high-risk districts for vaccination is a key strategy. The ChAd3-MARV vaccine, though still in its trial phase with uncertain protective effects, has been secured with 700 doses, and vaccinations have commenced for health workers.

Read more here from Key considerations: Outbreak of Marburg virus disease in Rwanda, October 2024 by Social Science in Humanitarian Action Platform. 

 



Article Type

Sector

Tanzania confirms Marburg Virus outbreak


Date Published

Mobilizes international support for containment efforts

Tanzania's President, Samia Suluhu Hassan, confirmed an outbreak of the deadly Marburg virus in the Kagera Region of northwestern Tanzania on January 20, 2025. The country has reported one confirmed case and 25 suspected cases, following laboratory tests that identified the infection. This outbreak marks Tanzania’s second encounter with the virus, following a previous outbreak in Bukoba District of Kagera in March 2023, which resulted in nine cases and six deaths.

The Marburg virus is a highly infectious disease, with a fatality rate as high as 88%. It is from the same family as the Ebola virus and is transmitted to humans primarily through fruit bats and monkeys. Victims present with symptoms typical of viral hemorrhagic fevers, including fever, headache, back pain, muscle weakness, diarrhea, vomiting blood, and external bleeding.

In response to the outbreak, the government initiated a rapid response plan, dispatching a team of public health experts to the area to monitor suspected cases and contain the spread. While 25 suspected cases have tested negative for the virus, the government has increased surveillance and response efforts to prevent further transmission.

The World Health Organization (WHO) has pledged $3 million from its contingency fund to support Tanzania’s efforts in containing the outbreak. WHO Director-General, Tedros Adhanom Ghebreyesus, emphasized the importance of continued investment in response capacity, which has been bolstered by Tanzania’s experience in managing the 2023 outbreak.

Simultaneously, the Africa Centers for Disease Control and Prevention (Africa CDC) is mobilizing immediate support, committing $2 million to help Tanzania manage the outbreak. A team of twelve public health experts, including epidemiologists, risk communication specialists, and infection prevention and control (IPC) experts, will be deployed to the region in the next 24 hours. Africa CDC’s support also includes the provision of diagnostic kits, genomic sequencing reagents, and technical assistance to enhance case detection and improve treatment protocols.

Dr. Jean Kaseya, Director-General of Africa CDC, expressed solidarity with Tanzania, highlighting the importance of swift action and coordinated efforts. “Building on Tanzania’s response capabilities from the 2023 outbreak, we are confident that, with our combined support, this outbreak will be controlled quickly,” he said.

This coordinated response effort, involving both international organizations like WHO and Africa CDC, as well as the Tanzanian government, underscores the urgent need for collaboration in managing the spread of the Marburg virus in the region. 

For more information:

Tanzania President Press Conference on MVD

Marburg Key Facts, Transmission, Symptoms, Diagnosis, Treatment

Tanzania Travel Advisory

MoH Press Release on Marburg

 




Article Type

Sector

New undiagnosed disease in DR Congo: urgent action needed - Lancet


Date Published

New undiagnosed disease in DR Congo: urgent action needed - Lancet

The outbreak of an undiagnosed disease in DR Congo, reported by WHO on Dec 8, 2024,1 is a pressing global health concern that demands swift and coordinated action. As of Dec 5, 406 cases and 31 deaths have been reported in the Panzi health zone in Kwango province, with influenza-like symptoms and anaemia. Most affected individuals are children aged younger than 5 years, many of whom are severely malnourished.

The remoteness of the region and poor infrastructure complicate the identification of the pathogen, with suspicions that multiple diseases could be contributing to these cases. Furthermore, the outbreak has the potential to transcend regional boundaries, particularly as DR Congo shares porous borders with Angola, where provinces such as Uige are vulnerable to cross-border transmission. Mobility between these regions could facilitate the spread of the disease to neighbouring African countries, raising the potential for a Public Health Emergency of International Concern.

With disease samples dispatched to Kinshasa for laboratory testing to determine the pathogen's origin, we are in a crucial window to prevent its further spread. Today, the approach must be different. The disease's unknown nature warrants containment measures at both the local and international levels. These measures should include the immediate restriction of cross-border movement in affected regions, enhanced disease surveillance, and the rapid mobilisation of health-care resources to DR Congo and neighbouring countries. Additionally, the international community must recognise that this is not solely an African challenge; it is a global health threat. Comprehensive funding and logistical support should be prioritised, enabling rapid diagnostic efforts, contact tracing, and the provision of personal protective equipment to front-line workers.

The risk of spillover into neighbouring countries underscores the urgency for Angola and other countries in the region to heighten preparedness measures. These measures should include deploying rapid response teams, establishing quarantine protocols, and intensifying public health communication to mitigate panic and misinformation. In this interconnected world, a delayed or fragmented response could allow this disease to evolve into a global health crisis. By learning from our recent past, we can change the trajectory of this outbreak and safeguard lives across continents. The experience with COVID-19 has shown that delays in responding to outbreaks can have catastrophic consequences. Therefore, it is imperative that the global community acts decisively to contain this undiagnosed disease in DR Congo, protecting not only African populations, but also global public health.

Reference

Undiagnosed disease—Democratic Republic of the Congo

https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON546



Article Type

Sector

Unraveling the mystery in the DRC’s disease outbreak—Is it Disease X?


Date Published

A recent outbreak of an undiagnosed illness in the Democratic Republic of the Congo is on the radar of public health professionals. Preparedness is key to mitigating the issue.

Photo: Testing for malnourishment in Democratic Republic of the Congo. Image courtesy of DFID – UK Department for International Development,

A recent outbreak of an undiagnosed illness in the Panzi health zone of the Democratic Republic of the Congo (DRC) has captured global attention, spotlighting the challenges of outbreak investigations in resource-limited settings. Since late October, over 400 cases have been reported, predominantly among children under five years old. Symptoms such as fever, cough, and body aches have resulted in 31 deaths, with severe malnutrition compounding the crisis.

This outbreak highlights the critical need for strong global public health systems to detect and respond to emerging health threats. Although the cause remains uncertain, investigators are exploring various possibilities, including endemic diseases like malaria and respiratory infections such as acute pneumonia, influenza, COVID-19, and measles. Malnutrition is thought to play a significant role in worsening disease severity. Laboratory testing is ongoing, and health officials are evaluating whether multiple diseases may be contributing to the cases and fatalities reported.

Read more here from an article in the New York Academy of Sciences: https://www.nyas.org/ideas-insights/blog/unraveling-the-mystery-in-the-drcs-disease-outbreak-is-it-disease-x/



Article Type

Sector

Why the mysterious ‘Disease X’ outbreak is so hard to investigate


Date Published

Photo: Roger Samuel Kamba, Minister of Public Health, Hygiene and Prevention.

The Democratic Republic of the Congo (DRC) is confronting a health crisis in the remote Panzi health zone of Kwango Province, where an undiagnosed illness has infected more than 400 people and killed at least 31, predominantly malnourished children under the age of five. The mystery “Disease X”—which may or may not be a new disease—causes symptoms such as fever, headache, cough, runny nose and body aches. The World Health Organization said in a press briefing on Tuesday that 10 out of 12 samples have tested positive for malaria, but it’s possible more than one disease is involved. The outbreak has raised pressing questions about the DRC’s ability to respond effectively to health emergencies in isolated areas.

Accessing Panzi is a formidable challenge, with poor road infrastructure requiring a multi-day journey from Kinshasa, the nation’s capital. “This is really the definition of remote,” says Placide Mbala, a virologist and head of epidemiology at the DRC’s National Institute of Biomedical Research. He explains that limited connectivity and delayed sample collection have hampered diagnosis efforts. Specimens collected initially were unsuitable for analysis, but a team from the DRC’s Ministry of Public Health has now gathered higher-quality samples, says Mbala, who is part of the team. Read more from the Publication, Scientific American, here .



Article Type

Sector

Unknown disease kills at least 79 people in DR Congo


Date Published

At least 79 people have died from an unknown disease that is causing flu-like symptoms in south-western Democratic Republic of Congo, the health ministry says.

Media reports quoting the health ministry says the majority of people who have died are between the ages of 15 and 18.

More than 300 people have been infected with patients exhibiting symptoms like fever, headaches, runny noses and coughs, breathing difficulties and anaemia.

Response teams have been sent to Kwango Province, specifically the Panzi health zone, where the disease is most common, to manage cases and investigate the nature of the disease. Symphorien Manzanza, a civil society leader, told Reuters news agency the situation was worrying as the number of infected people continues to rise.

"Panzi is a rural health zone, so there is a problem with the supply of medicines," he said.

A World Health Organisation (WHO) Africa region official told the BBC they have "dispatched a team to the remote area to collect samples for lab investigations".

Authorities have urged the population to remain calm and vigilant. They urged people to wash their hands with soap, avoid mass gatherings, and avoid touching the bodies of the deceased without qualified health personnel.

A local MP told Top Congo Radio that about 67 people had fallen sick and died between 10 and 26 November. "It should be noted that Panzi hospital is short of medicines to cope with this epidemic. We really need assistance," said the MP.



Article Type

Sector

EAC deploys experts to combat Mpox outbreak


Date Published

For the first time, the East African Community (EAC) is operationalising its Rapidly Deployable Expert (RDE) Pool in response to an international public health emergency due to the spreading Mpox virus disease outbreak. EAC Partner States such as the Democratic Republic of the Congo (DRC) and the Republic of Burundi are particularly affected, with the DRC reporting over 7,000 confirmed cases by end of October 2024, around 40% of them among children under 15.

The Rapidly Deployable Expert (RDE) Pool is a specialized team of trained health professionals and other experts within the East African Community (EAC) that can be quickly mobilized to assist member states in managing public health emergencies. The RDE Pool brings together experts in fields like epidemiology, environment, IT, laboratory science, logistics, risk communication, and clinical management, providing immediate, hands-on support in disease surveillance, response coordination, and healthcare provision during outbreaks. By deploying the RDE Pool, EAC enhances regional preparedness and strengthens each member state's capacity to address complex health crises effectively and efficiently. Read more on this link .



Article Type

Sector

Lessons learnt from the Marburg Virus Disease (MVD) outbreak in Tanzania


Date Published

Marburg virus

In March 2023, Tanzania faced a Marburg virus disease (MVD) outbreak in the Kagera region, impacting nine confirmed cases and resulting in six deaths. Through swift response actions, led by the Government of Tanzania and supported by Africa CDC and other health partners, the outbreak was contained within 78 days. Key factors in this success included strong political leadership, robust partnerships across sectors, and efficient use of existing health programs and resources. Regular coordination, multi-sectoral collaboration, and transparent communication were also pivotal in managing the crisis effectively, setting a benchmark for handling future outbreaks.

More details in an article by Africa CDC on this link .



Article Type

Sector